Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
KalVista Pharmaceuticals, Inc. (KALV) had Debt to Capital Ratio of 0.89 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$13.69M |
|
$-49.48M |
|
$1.23M |
|
$12.46M |
|
$59.74M |
|
$-46.05M |
|
$-1.27M |
|
$-47.33M |
|
$-47.33M |
|
$-49.48M |
|
$-49.48M |
|
$-49.48M |
|
$-49.48M |
|
$-46.05M |
|
$-46.05M |
|
53.88M |
|
53.88M |
|
$-0.92 |
|
$-0.92 |
|
| Balance Sheet Financials | |
$325.23M |
|
$3.19M |
|
$14.71M |
|
$339.93M |
|
$45.07M |
|
$139.03M |
|
$277.86M |
|
$322.93M |
|
$17.00M |
|
$17.00M |
|
$17.00M |
|
50.54M |
|
| Cash Flow Statement Financials | |
$-126.98M |
|
$19.87M |
|
$164.39M |
|
$182.98M |
|
$244.30M |
|
$61.32M |
|
$12.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.22 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.89 |
8.18 |
|
91.00% |
|
-336.33% |
|
-336.33% |
|
-- |
|
-345.64% |
|
-361.39% |
|
$-129.23M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
2.69 |
|
1.92 |
|
46.81 |
|
-291.09% |
|
-291.09% |
|
-14.56% |
|
-31.71% |
|
$0.34 |
|
$-2.40 |
|
$-2.36 |
|